nodes	percent_of_prediction	percent_of_DWPC	metapath
Temozolomide—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0805	0.126	CbGbCtD
Temozolomide—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0757	0.119	CbGbCtD
Temozolomide—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0757	0.119	CbGbCtD
Temozolomide—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0685	0.107	CbGbCtD
Temozolomide—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0685	0.107	CbGbCtD
Temozolomide—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0591	0.0925	CbGbCtD
Temozolomide—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0574	0.0898	CbGbCtD
Temozolomide—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.0519	0.0812	CbGbCtD
Temozolomide—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.0519	0.0812	CbGbCtD
Temozolomide—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0497	0.0779	CbGbCtD
Temozolomide—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000179	0.000496	CcSEcCtD
Temozolomide—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000179	0.000496	CcSEcCtD
Temozolomide—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000179	0.000495	CcSEcCtD
Temozolomide—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000179	0.000495	CcSEcCtD
Temozolomide—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000178	0.000494	CcSEcCtD
Temozolomide—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000178	0.000494	CcSEcCtD
Temozolomide—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000178	0.000493	CcSEcCtD
Temozolomide—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000178	0.000493	CcSEcCtD
Temozolomide—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000178	0.000493	CcSEcCtD
Temozolomide—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000177	0.000491	CcSEcCtD
Temozolomide—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000177	0.000491	CcSEcCtD
Temozolomide—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000177	0.000491	CcSEcCtD
Temozolomide—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000177	0.000489	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000176	0.000488	CcSEcCtD
Temozolomide—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000176	0.000487	CcSEcCtD
Temozolomide—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000176	0.000487	CcSEcCtD
Temozolomide—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000176	0.000487	CcSEcCtD
Temozolomide—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000176	0.000487	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000176	0.000486	CcSEcCtD
Temozolomide—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000176	0.000486	CcSEcCtD
Temozolomide—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000175	0.000486	CcSEcCtD
Temozolomide—Pain—Indinavir—acquired immunodeficiency syndrome	0.000175	0.000483	CcSEcCtD
Temozolomide—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000175	0.000483	CcSEcCtD
Temozolomide—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000174	0.000483	CcSEcCtD
Temozolomide—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000174	0.000483	CcSEcCtD
Temozolomide—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000174	0.000483	CcSEcCtD
Temozolomide—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000174	0.000482	CcSEcCtD
Temozolomide—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000174	0.000481	CcSEcCtD
Temozolomide—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000173	0.00048	CcSEcCtD
Temozolomide—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000173	0.00048	CcSEcCtD
Temozolomide—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000173	0.00048	CcSEcCtD
Temozolomide—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000173	0.000479	CcSEcCtD
Temozolomide—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000173	0.000479	CcSEcCtD
Temozolomide—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000173	0.000478	CcSEcCtD
Temozolomide—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000173	0.000478	CcSEcCtD
Temozolomide—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000172	0.000478	CcSEcCtD
Temozolomide—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000172	0.000476	CcSEcCtD
Temozolomide—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000172	0.000476	CcSEcCtD
Temozolomide—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000172	0.000476	CcSEcCtD
Temozolomide—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000171	0.000475	CcSEcCtD
Temozolomide—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000171	0.000474	CcSEcCtD
Temozolomide—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000171	0.000474	CcSEcCtD
Temozolomide—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000171	0.000473	CcSEcCtD
Temozolomide—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000171	0.000472	CcSEcCtD
Temozolomide—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.00017	0.000471	CcSEcCtD
Temozolomide—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.00017	0.000471	CcSEcCtD
Temozolomide—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.00017	0.00047	CcSEcCtD
Temozolomide—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000169	0.000469	CcSEcCtD
Temozolomide—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000168	0.000466	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000168	0.000465	CcSEcCtD
Temozolomide—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000168	0.000464	CcSEcCtD
Temozolomide—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000168	0.000464	CcSEcCtD
Temozolomide—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000167	0.000464	CcSEcCtD
Temozolomide—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000167	0.000464	CcSEcCtD
Temozolomide—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000167	0.000463	CcSEcCtD
Temozolomide—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000167	0.000463	CcSEcCtD
Temozolomide—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000167	0.000462	CcSEcCtD
Temozolomide—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000167	0.000462	CcSEcCtD
Temozolomide—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000167	0.000462	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000166	0.000461	CcSEcCtD
Temozolomide—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000166	0.000461	CcSEcCtD
Temozolomide—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000166	0.00046	CcSEcCtD
Temozolomide—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000166	0.00046	CcSEcCtD
Temozolomide—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000166	0.000459	CcSEcCtD
Temozolomide—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000166	0.000459	CcSEcCtD
Temozolomide—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000166	0.000458	CcSEcCtD
Temozolomide—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000165	0.000457	CcSEcCtD
Temozolomide—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000165	0.000457	CcSEcCtD
Temozolomide—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000165	0.000457	CcSEcCtD
Temozolomide—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000165	0.000457	CcSEcCtD
Temozolomide—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000165	0.000456	CcSEcCtD
Temozolomide—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000164	0.000455	CcSEcCtD
Temozolomide—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000164	0.000455	CcSEcCtD
Temozolomide—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000164	0.000455	CcSEcCtD
Temozolomide—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000164	0.000454	CcSEcCtD
Temozolomide—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000164	0.000454	CcSEcCtD
Temozolomide—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000163	0.000453	CcSEcCtD
Temozolomide—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000163	0.000453	CcSEcCtD
Temozolomide—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000163	0.000452	CcSEcCtD
Temozolomide—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000163	0.000451	CcSEcCtD
Temozolomide—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000163	0.00045	CcSEcCtD
Temozolomide—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000162	0.00045	CcSEcCtD
Temozolomide—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000162	0.000449	CcSEcCtD
Temozolomide—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000162	0.000449	CcSEcCtD
Temozolomide—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000161	0.000447	CcSEcCtD
Temozolomide—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000161	0.000447	CcSEcCtD
Temozolomide—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000161	0.000447	CcSEcCtD
Temozolomide—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000161	0.000446	CcSEcCtD
Temozolomide—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000161	0.000446	CcSEcCtD
Temozolomide—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000161	0.000445	CcSEcCtD
Temozolomide—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000161	0.000445	CcSEcCtD
Temozolomide—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.00016	0.000444	CcSEcCtD
Temozolomide—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.00016	0.000443	CcSEcCtD
Temozolomide—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.00016	0.000442	CcSEcCtD
Temozolomide—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.00016	0.000442	CcSEcCtD
Temozolomide—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.00016	0.000442	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000159	0.000441	CcSEcCtD
Temozolomide—Rash—Stavudine—acquired immunodeficiency syndrome	0.000159	0.000441	CcSEcCtD
Temozolomide—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000159	0.00044	CcSEcCtD
Temozolomide—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000159	0.00044	CcSEcCtD
Temozolomide—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000159	0.00044	CcSEcCtD
Temozolomide—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000159	0.00044	CcSEcCtD
Temozolomide—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000159	0.000439	CcSEcCtD
Temozolomide—Headache—Stavudine—acquired immunodeficiency syndrome	0.000158	0.000438	CcSEcCtD
Temozolomide—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000158	0.000438	CcSEcCtD
Temozolomide—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000158	0.000437	CcSEcCtD
Temozolomide—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000158	0.000437	CcSEcCtD
Temozolomide—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000158	0.000437	CcSEcCtD
Temozolomide—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000158	0.000437	CcSEcCtD
Temozolomide—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000157	0.000436	CcSEcCtD
Temozolomide—Rash—Abacavir—acquired immunodeficiency syndrome	0.000157	0.000434	CcSEcCtD
Temozolomide—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000157	0.000434	CcSEcCtD
Temozolomide—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000157	0.000434	CcSEcCtD
Temozolomide—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000157	0.000434	CcSEcCtD
Temozolomide—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000157	0.000433	CcSEcCtD
Temozolomide—Headache—Abacavir—acquired immunodeficiency syndrome	0.000156	0.000431	CcSEcCtD
Temozolomide—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000156	0.000431	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000155	0.00043	CcSEcCtD
Temozolomide—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000155	0.00043	CcSEcCtD
Temozolomide—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000155	0.00043	CcSEcCtD
Temozolomide—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000154	0.000427	CcSEcCtD
Temozolomide—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000154	0.000425	CcSEcCtD
Temozolomide—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000153	0.000425	CcSEcCtD
Temozolomide—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000153	0.000424	CcSEcCtD
Temozolomide—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000153	0.000424	CcSEcCtD
Temozolomide—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000152	0.000422	CcSEcCtD
Temozolomide—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000152	0.000422	CcSEcCtD
Temozolomide—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000152	0.000421	CcSEcCtD
Temozolomide—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000152	0.000421	CcSEcCtD
Temozolomide—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000152	0.000421	CcSEcCtD
Temozolomide—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000152	0.00042	CcSEcCtD
Temozolomide—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000151	0.000419	CcSEcCtD
Temozolomide—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000151	0.000418	CcSEcCtD
Temozolomide—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.00015	0.000417	CcSEcCtD
Temozolomide—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.00015	0.000416	CcSEcCtD
Temozolomide—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.00015	0.000416	CcSEcCtD
Temozolomide—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.00015	0.000416	CcSEcCtD
Temozolomide—Nausea—Stavudine—acquired immunodeficiency syndrome	0.00015	0.000415	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.00015	0.000414	CcSEcCtD
Temozolomide—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000149	0.000413	CcSEcCtD
Temozolomide—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000149	0.000411	CcSEcCtD
Temozolomide—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000148	0.000411	CcSEcCtD
Temozolomide—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000148	0.000409	CcSEcCtD
Temozolomide—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000147	0.000408	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000147	0.000408	CcSEcCtD
Temozolomide—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000147	0.000407	CcSEcCtD
Temozolomide—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000147	0.000406	CcSEcCtD
Temozolomide—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000146	0.000405	CcSEcCtD
Temozolomide—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000146	0.000405	CcSEcCtD
Temozolomide—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000146	0.000404	CcSEcCtD
Temozolomide—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000146	0.000404	CcSEcCtD
Temozolomide—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000146	0.000404	CcSEcCtD
Temozolomide—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000146	0.000404	CcSEcCtD
Temozolomide—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000146	0.000404	CcSEcCtD
Temozolomide—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000145	0.000402	CcSEcCtD
Temozolomide—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000145	0.0004	CcSEcCtD
Temozolomide—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000144	0.0004	CcSEcCtD
Temozolomide—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000143	0.000395	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000143	0.000395	CcSEcCtD
Temozolomide—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000142	0.000393	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000142	0.000393	CcSEcCtD
Temozolomide—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000142	0.000392	CcSEcCtD
Temozolomide—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000142	0.000392	CcSEcCtD
Temozolomide—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000141	0.00039	CcSEcCtD
Temozolomide—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000141	0.000389	CcSEcCtD
Temozolomide—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.00014	0.000389	CcSEcCtD
Temozolomide—Pain—Saquinavir—acquired immunodeficiency syndrome	0.00014	0.000389	CcSEcCtD
Temozolomide—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.00014	0.000387	CcSEcCtD
Temozolomide—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.00014	0.000387	CcSEcCtD
Temozolomide—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.00014	0.000386	CcSEcCtD
Temozolomide—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.00014	0.000386	CcSEcCtD
Temozolomide—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000139	0.000386	CcSEcCtD
Temozolomide—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000138	0.000383	CcSEcCtD
Temozolomide—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000138	0.000383	CcSEcCtD
Temozolomide—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000138	0.000383	CcSEcCtD
Temozolomide—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000138	0.000382	CcSEcCtD
Temozolomide—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000137	0.000381	CcSEcCtD
Temozolomide—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000136	0.000378	CcSEcCtD
Temozolomide—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000136	0.000377	CcSEcCtD
Temozolomide—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000136	0.000376	CcSEcCtD
Temozolomide—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000136	0.000375	CcSEcCtD
Temozolomide—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000135	0.000375	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000135	0.000375	CcSEcCtD
Temozolomide—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000135	0.000374	CcSEcCtD
Temozolomide—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000135	0.000374	CcSEcCtD
Temozolomide—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000135	0.000373	CcSEcCtD
Temozolomide—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000135	0.000373	CcSEcCtD
Temozolomide—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000134	0.000372	CcSEcCtD
Temozolomide—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000134	0.000371	CcSEcCtD
Temozolomide—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000134	0.000371	CcSEcCtD
Temozolomide—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000132	0.000367	CcSEcCtD
Temozolomide—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000132	0.000365	CcSEcCtD
Temozolomide—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000131	0.000361	CcSEcCtD
Temozolomide—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.00013	0.000361	CcSEcCtD
Temozolomide—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.00013	0.000361	CcSEcCtD
Temozolomide—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.00013	0.000359	CcSEcCtD
Temozolomide—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.00013	0.000359	CcSEcCtD
Temozolomide—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.00013	0.000359	CcSEcCtD
Temozolomide—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000129	0.000357	CcSEcCtD
Temozolomide—Rash—Indinavir—acquired immunodeficiency syndrome	0.000129	0.000356	CcSEcCtD
Temozolomide—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000129	0.000356	CcSEcCtD
Temozolomide—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000128	0.000355	CcSEcCtD
Temozolomide—Headache—Indinavir—acquired immunodeficiency syndrome	0.000128	0.000354	CcSEcCtD
Temozolomide—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000128	0.000353	CcSEcCtD
Temozolomide—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000126	0.00035	CcSEcCtD
Temozolomide—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000126	0.000348	CcSEcCtD
Temozolomide—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000124	0.000345	CcSEcCtD
Temozolomide—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000124	0.000343	CcSEcCtD
Temozolomide—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000124	0.000343	CcSEcCtD
Temozolomide—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000123	0.000339	CcSEcCtD
Temozolomide—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000122	0.000339	CcSEcCtD
Temozolomide—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000122	0.000338	CcSEcCtD
Temozolomide—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000122	0.000337	CcSEcCtD
Temozolomide—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000121	0.000336	CcSEcCtD
Temozolomide—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000121	0.000336	CcSEcCtD
Temozolomide—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000121	0.000335	CcSEcCtD
Temozolomide—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000121	0.000335	CcSEcCtD
Temozolomide—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000121	0.000334	CcSEcCtD
Temozolomide—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000118	0.000326	CcSEcCtD
Temozolomide—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000117	0.000325	CcSEcCtD
Temozolomide—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000117	0.000323	CcSEcCtD
Temozolomide—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000116	0.000322	CcSEcCtD
Temozolomide—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000116	0.000322	CcSEcCtD
Temozolomide—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000116	0.000322	CcSEcCtD
Temozolomide—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000116	0.00032	CcSEcCtD
Temozolomide—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000115	0.00032	CcSEcCtD
Temozolomide—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000115	0.000317	CcSEcCtD
Temozolomide—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000113	0.000312	CcSEcCtD
Temozolomide—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000112	0.000311	CcSEcCtD
Temozolomide—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000112	0.000311	CcSEcCtD
Temozolomide—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000111	0.000307	CcSEcCtD
Temozolomide—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.00011	0.000303	CcSEcCtD
Temozolomide—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000109	0.000301	CcSEcCtD
Temozolomide—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000108	0.0003	CcSEcCtD
Temozolomide—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000108	0.000298	CcSEcCtD
Temozolomide—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000107	0.000298	CcSEcCtD
Temozolomide—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000107	0.000297	CcSEcCtD
Temozolomide—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000107	0.000296	CcSEcCtD
Temozolomide—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000104	0.000289	CcSEcCtD
Temozolomide—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000104	0.000287	CcSEcCtD
Temozolomide—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000104	0.000287	CcSEcCtD
Temozolomide—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000103	0.000286	CcSEcCtD
Temozolomide—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000103	0.000285	CcSEcCtD
Temozolomide—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000101	0.000281	CcSEcCtD
Temozolomide—Vomiting—Lamivudine—acquired immunodeficiency syndrome	9.96e-05	0.000276	CcSEcCtD
Temozolomide—Rash—Lamivudine—acquired immunodeficiency syndrome	9.88e-05	0.000274	CcSEcCtD
Temozolomide—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	9.87e-05	0.000273	CcSEcCtD
Temozolomide—Headache—Lamivudine—acquired immunodeficiency syndrome	9.81e-05	0.000272	CcSEcCtD
Temozolomide—Nausea—Saquinavir—acquired immunodeficiency syndrome	9.75e-05	0.00027	CcSEcCtD
Temozolomide—Nausea—Lamivudine—acquired immunodeficiency syndrome	9.31e-05	0.000258	CcSEcCtD
